Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

The CheckMate™ Mammalian Two-Hybrid System

Elaine Schenborn1, Lisa deBerg1 and William Brondyk2
1Promega Corporation; 2Ares Advanced Technologies
Publication Date: 1998

Abstract

Two-hybrid systems provide powerful methods for detecting protein:protein interactions in vivo. The two-hybrid system, originally developed in yeast, has been adapted for use in mammalian cells. Promega recently introduced the CheckMate™ Mammalian Two-Hybrid System, which allows protein:protein interactions to be studied in the cell line of choice. In this article, the CheckMate™ Mammalian Two-Hybrid System is demonstrated in HeLa, NIH3T3 and CHO mammalian cell lines, as well as used to confirm in vivo association of the cloned Raf-1 kinase and oncogenic Ras proteins.

Promega Notes 66, 2.

Related Resources